Trial reportAnnals of behavioral medicine : a publication of the Society of Behavioral Medicine2014
Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs.
Trial report in Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Reporting quality of sham needles used as controls in acupuncture trials: a methodological evaluation.Chinese medicine · 2022Article
- Evaluation of adverse drug reaction formatting in drug information mobile phone applications.Journal of the Medical Library Association : JMLA · 2022Article
- Evaluation of adverse drug reaction formatting in drug information databases.Journal of the Medical Library Association : JMLA · 2020Article
- Adverse drug reactions in drug information databases: does presentation affect interpretation?Journal of the Medical Library Association : JMLA · 2020Article
- Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.Patient education and counseling · 2016Article
- Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals.BMC health services research · 2015Article
- The FDA's Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health Equity.Journal of primary care & community healthArticle
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
backgroundResearch suggests that quantitative information in direct-to-consumer (DTC) prescription drug ads may be helpful for consumers. PURPOSE: The objective was to examine the effect of adding placebo rates and framing to DTC ads.
methodsIn study 1, 2,000 Internet panel members with chronic pain participated in a randomized controlled experiment of DTC ads varying in placebo rate and framing. In study 2, 596 physicians ranked DTC ads varying in placebo rate and framing by how well they conveyed scientific information and their usefulness for patients.
resultsIn study 1, participants who viewed placebo rates were able to recall them and use them to form certain perceptions. A mixed frame led to lower placebo rate recall and perceived efficacy. In study 2, overall, physicians preferred a placebo/single frame ad.
conclusionsAdding placebo rates to DTC ads may be useful for consumers. The evidence does not support using a mixed frame.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.